Metabolic and Bariatric Surgery · 13 November 2023

A Deep Dive into Anti-Obesity Medications

The battle against obesity is no one-size-fits-all, and this study delves into the arsenal—lifestyle tweaks, anti-obesity meds (AOMs), gadgets, and surgery. Researchers stress the need for a personalized approach, factoring in patient quirks, goals, and health hiccups. In this trial-and-error game, no crystal ball predicts the perfect AOM match. The takeaway? Prescribe sequentially, maybe mix and match, to hit that sweet spot in the fight against the bulge.

Review by Schmitz SH and Aronne LJ in Gastroenterol Clin North Am

read the whole article in Gastroenterol Clin North Am

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

Ann Surg13 Jul 2026

Predictive Models Enhance Diabetes Remission After Surgery

A new calculator predicts type 2 diabetes remission outcomes for patients post-metabolic surgery, improving patient selection.

Ann Surg16 Jun 2026

EndoBarrier Shows Promise for Type 2 Diabetes in Obesity

Endoscopic duodenal-jejunal bypass liner may significantly improve glycemic control and weight loss in patients with poorly controlled type 2 diabetes and obesity.

All papers in Metabolic and Bariatric Surgery →